UEMR for Medium-sized Pedunculated Colon Polyps
The Use of Underwater Endoscopic Mucosal Resection for Medium-sized Pedunculated Colon Polyps: A Prospective Observational Study
1 other identifier
observational
32
1 country
1
Brief Summary
Underwater EMR (UEMR) is an emerging technique for endoscopic resection. The purpose of this research is to observ wether the UEMR for medium-sized pedunculated polyps is safe and effective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2021
CompletedFirst Posted
Study publicly available on registry
April 8, 2021
CompletedStudy Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedApril 8, 2021
April 1, 2021
4 months
April 7, 2021
April 7, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
The rate of bleeding
the bleeding was defined as the active hemorrhage lasted for ≥ 30 s or other condition requires immediate intervention.
1 Day of colonoscopy
Study Arms (1)
UEMR
Interventions
(1) the colorectal lumen was completed deflated with 500-1000 mL sterile water using a flushing pump; (2) the lesion and 2-3 mm of normal mucosa surrounding the base of the polyp were snared and subsequently resected with an electrosurgical generator
Eligibility Criteria
Outpatients or inpatients requiring polypectomy
You may qualify if:
- Patients age between 18-75 years old with pedunculated colonic polyps (measuring between 10 and 20mm), who willing to participate in this study.
You may not qualify if:
- pregnancy,
- inflammatory bowel disease,
- familial polyposis
- the use of anticoagulant therapy or antiplatelet therapy
- the absence of informed patient consent.
- Polyps showing signs of deep submucosal invasion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ningbo First Hospital
Ningbo, Zhejiang, 315010, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2021
First Posted
April 8, 2021
Study Start
May 1, 2021
Primary Completion
September 1, 2021
Study Completion
October 1, 2021
Last Updated
April 8, 2021
Record last verified: 2021-04